Dr. Stuart E. Selonick, MD

Dr. Selonick practices at Summit Ambulatory Surgical Center, LLC in Annapolis, Maryland.

Dr. Selonick's NPI, 1457389561, was assigned on June 29, 2006. Dr. Selonick graduated from Johns Hopkins University School of Medicine in 1975. Dr. Selonick holds Maryland license D016364.

Dr. Selonick's primary practice is Summit Ambulatory Surgical Center, LLC, at 810 Bestgate Rd, Annapolis, MD 21401 in Anne Arundel County. The practice phone is (855) 405-7100.

Dr. Selonick's primary practice is Summit Ambulatory Surgical Center, LLC in Annapolis, Maryland. Dr. Selonick is also affiliated with Luminis Health Anne Arundel Medical Center. The medical group on file is Johns Hopkins University. Dmand AI also links Dr. Selonick to 3 more group practices and clinics, 2 home health agencies, 2 medical groups and 1 hospice, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Selonick practices, 7 sites in all. Vendor and product names are available with a free account.

Hematology and oncology is Dr. Selonick's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dr. Selonick is licensed in Maryland.

CMS data shows 51,391 Medicare services from Dr. Selonick across 39 procedure codes in 2024, for 883 Medicare patients. Medicare paid $905,034 for them. Every service was in an office.

CMS counts 883 Medicare patients who saw Dr. Selonick in 2024. The largest group is 75 to 84, with 372 patients. 75% of them have high cholesterol, and 72% have high blood pressure. 5% are also on Medicaid. Their average risk score is 1.66, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Selonick's median patient age at 70, with 53% women.

In 2024, Dr. Selonick wrote 1,353 Medicare Part D claims for 159 patients. 77% of them were for generic drugs. CMS names the drug for 1,051 of them, across 47 drugs with 11 or more claims each, at $2,879,021 in total drug cost. In 2023, CMS named 738 claims across 35 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 88 out of 100 for Dr. Selonick for performance year 2024, reported individually. Dr. Selonick accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Selonick as offering telehealth.

CMS Open Payments shows 497 general payments to Dr. Selonick from 71 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 99% of the total. Novartis Pharmaceuticals Corporation paid the most, $1,368.

Dr. Selonick graduated from Johns Hopkins University School of Medicine in 1975.